David Chu, MD, PhD has served as Executive Director, Clinical Development, at Arcutis Biotherapeutics since January 2021. Dr. Chu earned his medical degree and immunology doctorate from UC San Francisco. He trained in dermatology at NYU, joining the faculty as Assistant Clinical Professor after residency, while also completing a postdoctoral research fellowship at Rockefeller University studying stem cells of the hair follicle and epidermis. Following a transition to full-time clinical medicine, he maintained a diverse clinical practice focused on immune-mediated dermatologic disorders, including as Director of Contact Dermatitis at Scripps Clinic Medical Group in San Diego until 2019, when he entered the pharmaceutical industry, joining Janssen as Director, Clinical Development in Immunology/Dermatology.